Evolus, Inc. (NASDAQ:EOLS) Q3 2023 Earnings Call Transcript

Page 5 of 5

We are fully funded to achieve that growth, and we have an experienced team in place to execute our growth plans. This category is in transition from pharma to beauty from an older generation of users to the millennials and our cash-pay focus enables us to uniquely partner with practices through first-in-class programs like our co-branded media which help accelerate practice growth and profitability. With our business model focused on the skin market, we have built a moat from our competitors. This is a unique and sustainable competitive advantage for Evolus, the benefits of which are evident in our pace of growth and strong financial results. Note, we will be participating at the Stifel conference in New York on November 14 and 15, and at the Evercore Healthcare Conference in Miami on November 28.

We look forward to seeing you there. Thank you all for joining us today.

Operator: You may now disconnect your lines.

Follow Evolus Inc.

Page 5 of 5